Clinical Trial Update: Study of Efficacy, Safety of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3001 [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of fulranumab as an adjunctive treatment for osteoarthritis of the hip or knee has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis

Drugs mentioned

• Fulranumab (fulranumab)

Snippet

Sponsor: Janssen Research & Development, LLC | Conditions: Osteoarthritis, Pain | Phase 3 | Status: COMPLETED